The official blog of the Lung Institute.

Is Emphysema Curable?

8 Aug 2017
| Under Emphysema, Lung Disease | Posted by | 0 Comments
Lung Graphic

There is no cure for emphysema, but certain treatment methods may help ease the uncomfortable symptoms associated with the condition. Emphysema is a type of chronic obstructive pulmonary disease (COPD) that causes shortness of breath. Symptoms may be mild at first, but can worsen and negatively impact quality of life as the disease progresses.

Traditional treatment for emphysema focuses on improving breathing and reducing coughing episodes through methods like supplemental oxygen, bronchodilators and inhaled steroids. Many emphysema patients also participate in pulmonary therapy to help promote lung function and improve their ability to exercise without feeling breathless. In severe cases where traditional treatments are not effective, lung transplantation may be recommended.

While there is not yet a treatment that can totally reverse the effects of emphysema, autologous stem cell therapy has shown promising results as an alternative course of care in certain patients with COPD. This treatment involves utilizing the patient’s own stem cells to promote natural healing within the lungs. Many COPD patients who have received stem cell therapy have reported an improvement in their overall quality of life following the procedure.

The Lung Institute is the nation’s only stem cell therapy center focused exclusively on addressing lung disease. We encourage you to contact us at (800) 729-3065 if your emphysema symptoms are not responding to traditional treatment methods. Our devoted and compassionate medical team will be happy to discuss how stem cell therapy may be able to improve your quality of life and determine if you are a candidate for emphysema treatment.

Your Comment

Your email address will not be published.

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. The Lung Institute is firmly in accordance with the conditions set by the FDA for exemption status and conducts itself in full accordance with current guidelines. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and stem cell procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.